Jitesh Pratap to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Jitesh Pratap has written about Xenograft Model Antitumor Assays.
Connection Strength
0.092
-
The histone deacetylase inhibitor, vorinostat, reduces tumor growth at the metastatic bone site and associated osteolysis, but promotes normal bone loss. Mol Cancer Ther. 2010 Dec; 9(12):3210-20.
Score: 0.092